In What Could be a First, Drug Maker Gives Providers Deadline to Request 340B Overcharge Refunds
Generic and over-the-counter drug manufacturer VistaPharm said in a public notice this week that it has identified 340B covered entities [...]
*Sign up for news summaries and alerts from 340B Report